Table: Torii Pharmaceutical -2021 parent results
Feb 10 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2021 Dec 31, 2020 Dec 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 46.99 41.70 48.20
(+12.7 pct) (-3.0 pct)
Operating 4.66 4.74 5.20
(-1.7 pct) (+231.2 pct) (+11.7 pct)
Recurring 4.85 4.97 5.40
(-2.5 pct) (+193.8 pct) (+11.4 pct)
Net 3.37 3.50 3.80
(-3.5 pct) (-87.2 pct) (+12.6 pct)
EPS 120.13 yen 124.47 yen 135.27 yen
EPS Diluted 124.46 yen
Ann Div 48.00 yen 48.00 yen 48.00 yen
-Q2 Div 24.00 yen 24.00 yen 24.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)